BRCA1 and neoplasm: In patients whose tumor exhibit HR deficiency, e.g., through BRCA1/2 mutations, double-stranded DNA (dsDNA) repair is impaired, leading to cells becoming increasingly reliant on PARP as a primary mechanism of DDR and in turn, making them exquisitely sensitive to PARP inhibition [8] (Figure 1).